|
![]() |
|
|
mecamylamine_hydrochloride: profile and news
Other information Indication For the treatment of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension Pharmacology Mecamylamine is a potent, oral antihypertensive agent and ganglion blocker, and is a secondary amine. Mecamylamine is indicated for the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension. Mecamylamine reduces blood pressure in both normotensive and hypertensive individuals. A small oral dosage often produces a smooth and predictable reduction of blood pressure. Although this antihypertensive effect is predominantly orthostatic, the supine blood pressure is also significantly reduced. Mecamylamine crosses the blood-brain and placental barriers. Mechanism Of Action Mecamylamine is a ganglionic blocker which prevents stimulation of postsynaptic receptors by acetylcholine released from presynaptic nerve endings. The hypotensive effect of Mecamylamine is attributed to reduction in sympathetic tone, vasodilation, and reduced cardiac output, and is primarily postural. Drug Category Antihypertensive Agents; Nicotinic Receptor Antagonist ATC:C02BB01 Brand Names/Synonyms Versamine; Inversine; Revertina; Inversine hydrochloride; Mecamilamina; Mecamine; Mecamine hydrochloride; Mecamylamine Hydrochloride; Mekamin hydrochloride; Mekamine; Mevasin hydrochloride; Mevasine; 2-Methylamino-2,3,3-trimethylnorbornane; 2-Methylaminoisocamphane; 2-Norbornanamine, N,2,3,3-tetramethyl-; 2-Norbornanamine, N,2,3,3-tetramethyl-, hydrochloride; 3-Methylaminoisocamphane; 3-Methylaminoisocamphane hydrochloride Dosage Forms Tablets Absorption Mecamylamine is almost completely absorbed from the gastrointestinal tract Interactions Interactions for Mecamylamine: Patients receiving antibiotics and sulfonamides generally should not be treated with ganglion blockers. The action of Mecamylamine may be potentiated by anesthesia, other antihypertensive drugs and alcohol. Chemical IUPAC Name N,2,3,3-tetramethylnorbornan-2-amine Chemical Formula C11H21N Half Life Not Available Drug Type Approved Drug # Accession No APRD00458 CAS Registry Number 60-40-2 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |